Minor Project-2: Title
Minor Project-2: Title
Title:
Alzheimer MRI Classification and detection using ResNet and
Presented by:
CNN
Roll number - R2142210380
Name-Jatin Duindi
Roll number - R2142210698
Name-Sanskriti Bhardwaj Mentored By:
Roll number - R2142210837 Dr. Virendra Kadyan
Name-Vansh Kataria
Roll number - R2142210096
Name-Amil Lal
Roll Number- R2142210096
Content
● Introduction
● Literature Review
● Objectives
● Methodology
● Pert Chart
● References
Introduction
● The quest for early detection of Alzheimer's disease (AD) has prompted extensive research into the
application of classification methods, leveraging various data modalities.
● Neuroimaging studies, such as those by Smith et al.[2], have employed magnetic resonance imaging
(MRI) and positron emission tomography (PET) data for distinguishing AD patients from healthy
controls.
● Concurrently, investigations by Chen et al.[2] have explored the potential of cognitive test scores and
biomarkers in AD detection, indicating a multifaceted approach to understanding the disease.
● Integrative studies, like the work of Wang et al.[5], have delved into the combination of genetic and
omics data, providing a holistic perspective on the pathology.
● The application of diverse machine learning algorithms, from traditional classifiers to deep learning
architectures, has shown promise, with Li et al.[1] comparing their performance and delineating their
respective strengths and limitations.
Technical Concepts (Algorithms) used
Statistical Analysis Steps:
Classifier Algorithms:
● CNNs: These deep learning models are adept at processing visual data like images. They are employed here to extract meaningful features from
MRI images and classify them into different stages of Alzheimer's disease.
● ResNet152V2: Residual Networks (ResNets) are a type of CNN architecture known for their depth, which enables them to capture intricate
patterns in images. ResNet152V2, a variant of ResNet, is used for its superior performance in image classification tasks. It's pre-trained on large
datasets and fine-tuned with transfer learning on the specific Alzheimer's MRI dataset to improve classification accuracy.
Motivation
Alzheimer's disease (AD) stands as a prevalent and challenging neurodegenerative disorder, necessitating
accurate and early detection for effective intervention. This literature review delves into recent advancements
in AD detection models, emphasizing the integration of advanced classification methods. Neuroimaging
studies, notably the work by Smith et al. (2022), showcase the efficacy of utilizing structural MRI and PET
data for distinguishing AD patients from healthy counterparts. Concurrently, Chen et al. (2020) explore the
potential of cognitive test scores and blood biomarkers, while integrative studies advocate for a holistic
understanding through the incorporation of genetic and omics data. Assessing machine learning algorithms,
Zhang et al. (2021) contribute insights into the performance variations of classifiers like Random Forest and
Neural Networks in AD classification.
Inference from Literature
We have infer the following from our Literature Survey:
We also found that there are many advantages of using CNN-ResNet101 over Vanilla-CNN as
follows:
Main Objective
To develop and implement machine learning algorithms capable of accurately detecting
early signs of Alzheimer's disease through cognitive and physiological assessments. The
project aims to create a scalable model that enhances early diagnosis, facilitates
personalized treatment plans, and ultimately improves patient outcomes in the field of
neurology and geriatrics
Sub Objective
To achieve this overarching goal, we will establish sub-objectives that focus on specific aspects of
model development and implementation. These sub-objectives will include:
● Data Acquisition and Preprocessing
● Model Training and Optimization
● Model Evaluation and Validation
Methodology
Objective
Develop ML model to detect Alzheimer's.
Data Collection
Patient demographics, genetic data, brain scans, cognitive tests.
Preprocessing
Clean, normalize, and split data.
Feature Engineering
Extract and select key features.
Model Development
Choose algorithms (CNN,ResNet).
Train and validate models.
Evaluation
Test model accuracy (use metrics like sensitivity, specificity).
Optimization
Tune parameters, validate.
Deployment
Implement model in clinical tool.
Monitoring
Track performance, update as needed.
Timeline
Deliverable of each steps
● Data Acquisition and Preprocessing
Deliverable: A well-structured, cleaned, and preprocessed dataset containing Magnetic
Resonance Images(MRI) have been preprocessed.
Data cleaning procedures (handling missing values, outliers)
Descriptive statistics summarizing the data
[2] W. Chen et al., Whether cognitive behavioral therapy is effective for alzheimer’s disease: A protocol for bayesian network meta-analysis , Oct. 2020.
doi:10.37766/inplasy2020.10.0076
[3] T. Tripathi and R. Kumar, Speech-based detection of multi-class alzheimer disease classification using machine learning, Apr. 2023. doi:10.21203/rs.3.rs-
2825728/v1
[4] Kavitha C, Mani V, Srividhya SR, Khalaf OI, Tavera Romero CA. Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models. Front Public
Health. 2022 Mar 3;10:853294. doi: 10.3389/fpubh.2022.853294. PMID: 35309200; PMCID: PMC8927715.
[5] X.-X. Zhang et al., “The epidemiology of alzheimer’s disease modifiable risk factors and prevention,” The Journal of Prevention of Alzheimer’s Disease, pp.
1–9, 2021. doi:10.14283/jpad.2021.15
Thank You